Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Conditions
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndromes
- Hematological Malignancies
- B-cell Malignancy, Low-grade
- Myelodysplastic Syndrome With Low-grade Lesions
- IgG Monoclonal Gammopathy of Uncertain Significance
- Smoldering Multiple Myeloma
- Waldenstrom Macroglobulinemia
Sponsor
Dana-Farber Cancer Institute
Collaborators